[Our clinical experience with sulpiride in psychiatry].
D000208:Acute Disease; D000275:Adjustment Disorders / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000188:drug therapy; D001288:Attention / Q000187:drug effects; D001565:Benzoates / Q000627:therapeutic use*; D002908:Chronic Disease; D003693:Delirium / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009461:Neurologic Manifestations; D009497:Neurotic Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy; D011759:Pyrrolidines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use
D001565:Benzoates; D011759:Pyrrolidines; D013449:Sulfonamides; D014149:Tranquilizing Agents
Notre expérience clinique du sulpiride en psychiatrie.